From: Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach
Name | pvalue | Number of genes | Percentage in tGDE | Percentage in function |
---|---|---|---|---|
Diseases and disorders | ||||
Infectious disease | 2.70E−15 to 3.60E−03 | 1,097 | 12.3 | 32.5 |
Respiratory disease | 9.97E−12 to 4.57E−03 | 194 | 2.2 | 5.7 |
Organismal injury and abnormalities | 2.56E−10 to 5.01E−03 | 316 | 3.6 | 8.6 |
Dermatological diseases and conditions | 5.33E−10 to 3.80E−03 | 295 | 3.3 | 9.9 |
Renal and urological disease | 7.73E−10 to 7.73E−10 | 206 | 2.3 | 8.7 |
Molecular and cellular functions | ||||
Cellular development | 3.15E−14 to 5.88E−03 | 933 | 10.5 | 15.6 |
RNA post-transcriptional modification | 4.22E−14 to 8.93E−04 | 196 | 2.2 | 45.1 |
Cell death | 3.53E−13 to 6.16E−03 | 1,880 | 21.2 | 30.7 |
Cellular function and maintenance | 8.28E−12 to 5.94E−03 | 739 | 8.3 | 13.4 |
Cell morphology | 1.16E−09 to 4.80E−03 | 400 | 4.5 | 8.9 |
Physiological system development and function | ||||
Hematological system development and function | 3.88E−15 to 6.17E−03 | 1,158 | 13.0 | 29.7 |
Hematopoiesis | 3.88E−15 to 4.66E−03 | 681 | 7.7 | 38.4 |
Lymphoid tissue structure and development | 5.06E−11 to 5.10E−03 | 528 | 5.9 | 35.4 |
Cell-mediated immune response | 2.16E−10 to 1.80E−03 | 305 | 3.4 | 33.0 |
Tissue morphology | 2.52E−10 to 4.84E−03 | 628 | 7.1 | 14.0 |